The Porphyrins 1979
DOI: 10.1016/b978-0-12-220106-6.50018-8
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Chemistry of the Porphyrins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1989
1989
2021
2021

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 229 publications
0
2
0
Order By: Relevance
“…Soluble and insoluble VHb polypeptide levels were determined by quantitative SDS-PAGE. Heme levels were determined by the pyridine hemochromogen assay using visible difference absorption spectroscopy (4).…”
Section: Methodsmentioning
confidence: 99%
“…Soluble and insoluble VHb polypeptide levels were determined by quantitative SDS-PAGE. Heme levels were determined by the pyridine hemochromogen assay using visible difference absorption spectroscopy (4).…”
Section: Methodsmentioning
confidence: 99%
“…A hematoporphyrin derivative, Photofrin (dihematoporphyrin ether and/or ester) (Axcan Pharma, Quebec, Canada) is used as the photosensitizer in PDT. Hematoporphyrin derivatives exhibit red fluorescence when light of wavelengths around 405nm is radiated [3]. It is reported that Photofrin is retained selectively by tumor tissue compared with most normal tissues [4] except the liver, spleen, and kidney [5,6].…”
mentioning
confidence: 99%